Opportunity
Simpler Grants.gov #FOR-AR-25-006
NIAMS Ancillary Clinical Research Studies Grant Opportunity
Buyer
National Institutes of Health
Posted
June 12, 2025
Respond By
April 06, 2026
Identifier
FOR-AR-25-006
NAICS
541715
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), is seeking applications for research grants supporting ancillary studies that leverage ongoing clinical projects. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Purpose: - Fund ancillary studies that utilize resources from existing parent clinical studies (e.g., patient cohorts, infrastructure, data, biological samples) - Advance research in areas relevant to the NIAMS mission - Funding Details: - Total funding amount: $2,000,000 - Expected number of awards: 4 - Funding instrument: Grant - Eligibility: - Open to nonprofits, educational institutions, government agencies, and businesses - Collaboration: - Encourages collaborative research among investigators with relevant expertise - Products/Services Requested: - No specific products, OEMs, or part numbers are mentioned - Primary service is research leveraging existing clinical study resources - Unique Requirements: - Studies must be ancillary to ongoing parent clinical projects - Focus on diseases and conditions within the NIAMS mission - Place of Performance: - National Institutes of Health (NIH)
Description
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is soliciting applications for research on ancillary studies that leverage resources from ongoing parent clinical studies, including patient cohorts, infrastructure, data, and biological samples. The ancillary studies should align with the NIAMS mission, even if the parent studies are outside this mission. The opportunity encourages collaboration among investigators with expertise in diseases within the NIAMS mission and those skilled in leveraging clinical research. The funding instrument is a grant with a total funding amount of $2,000,000 and an expected four awards.